Giunchedi, Paolo

Nanoemulsions for “Nose-to-Brain” Drug Delivery

Bonferoni, M. C., Rossi, S., Sandri, G., Ferrari, F., Gavini, E., Rassu, G., & Giunchedi, P. (2019) · Pharmaceutics

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 269

Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer’s therapy

Rassu, G., Soddu, E., Posadino, A. M., Pintus, G., Sarmento, B., Giunchedi, P., & Gavini, E. (2017) · Colloids and Surfaces B: Biointerfaces

Advanced Drug Delivery SystemsRNA Interference and Gene Delivery

Cited by 239

Intranasal Delivery of Genistein-Loaded Nanoparticles as a Potential Preventive System against Neurodegenerative Disorders

Rassu, G., Porcu, E. P., Fancello, S., Obinu, A., Senes, N., Galleri, G., Migheli, R., Gavini, E., & Giunchedi, P. (2018) · Pharmaceutics

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 107

Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review

Rassu, G., Soddu, E., Cossu, M., Gavini, E., Giunchedi, P., & Dalpiaz, A. (2016) · Journal of Drug Delivery Science and Technology

Advanced Drug Delivery SystemsInhalation and Respiratory Drug Delivery

Cited by 87

Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries

Dalpiaz, A., Fogagnolo, M., Ferraro, L., Capuzzo, A., Pavan, B., Rassu, G., Salis, A., Giunchedi, P., & Gavini, E. (2015) · Antiviral Research

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 63

Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting

Gavini, E., Rassu, G., Ferraro, L., Beggiato, S., Alhalaweh, A., Velaga, S., Marchetti, N., Bandiera, P., Giunchedi, P., & Dalpiaz, A. (2013) · European Journal of Pharmaceutics and Biopharmaceutics

Advanced Drug Delivery SystemsInhalation and Respiratory Drug Delivery

Cited by 62

Neuroprotective Effects of Engineered Polymeric Nasal Microspheres Containing Hydroxypropyl-β-cyclodextrin on β-Amyloid (1-42)-Induced Toxicity

Yalcin, A., Soddu, E., Turunc Bayrakdar, E., Uyanikgil, Y., Kanit, L., Armagan, G., Rassu, G., Gavini, E., & Giunchedi, P. (2016) · Journal of Pharmaceutical Sciences

Alzheimer's disease research and treatmentsAdvanced Drug Delivery Systems

Cited by 37

Prolonged skin retention of clobetasol propionate by bio-based microemulsions: A potential tool for scalp psoriasis treatment

Langasco, R., Tanrıverdi, S. T., Özer, Ö., Roldo, M., Cossu, M., Rassu, G., Giunchedi, P., & Gavini, E. (2018) · Drug Development and Industrial Pharmacy

Advancements in Transdermal Drug DeliveryAdvanced Drug Delivery Systems

Cited by 25

Hydroxypropyl-β-Cyclodextrin Formulated in Nasal Chitosan Microspheres as Candidate Therapeutic Agent in Alzheimer’s Disease

Rassu, G., Gavini, E., Carta, A., Obinu, A., Porcu, E. P., & Giunchedi, P. (2018) · Current Drug Delivery

Advanced Drug Delivery SystemsAlzheimer's disease research and treatments

Cited by 8